Larry Schlabach
Impact in
-
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 3
- Lung Cancer Diagnosis and Treatment 2
- Oncology 8
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 2
- Co-authors
- Yu Shyr (5 shared papers)David H. Johnson (3 shared papers)F. Yunus (3 shared papers)Kenneth R. Hande (2 shared papers)Russell F. DeVore (2 shared papers)Hak Choy (2 shared papers)Lester Porter (1 shared paper)Furhan Yunus (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Cancer Medicine (1 paper)Journal of Thoracic Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Larry Schlabach
10 papers receiving 296 citations
Peers
Comparison fields: 5 of 46
- Oncology 185
- Pulmonary and Respiratory Medicine 151
- Radiation 34
- Otorhinolaryngology 12
- Cancer Research 27
Countries citing papers authored by Larry Schlabach
This map shows the geographic impact of Larry Schlabach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Schlabach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Schlabach more than expected).
Fields of papers citing papers by Larry Schlabach
This network shows the impact of papers produced by Larry Schlabach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Schlabach. The network helps show where Larry Schlabach may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry Schlabach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 81 | |
| 2 | 2004 | 69 | |
| 3 | In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity. | 1993 | 35 |
| 4 | Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. | 2001 | 34 |
| 5 | 2014 | 28 | |
| 6 | Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer. | 1997 | 18 |
| 7 | 2009 | 16 | |
| 8 | 2004 | 12 | |
| 9 | 2011 | 4 | |
| 10 | 2004 | 3 |
About Larry Schlabach
Larry Schlabach is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 10 papers that have together received 300 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer therapeutics and mechanisms (2 papers), Lung Cancer Research Studies (2 papers), Advanced Radiotherapy Techniques (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Oncology (185 citations), Pulmonary and Respiratory Medicine (151 citations), Radiation (34 citations), Otorhinolaryngology (12 citations) and Cancer Research (27 citations). Larry Schlabach has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Yu Shyr, David H. Johnson, F. Yunus, Kenneth R. Hande, Russell F. DeVore, Hak Choy, Lester Porter, Furhan Yunus, Howard Safran and Bruce E. Johnson. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Medicine, Journal of Thoracic Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.